General Scientific Aspects of Personalised Medicine: The Healthcare Biotech Industry Perspective
On 19 March 2010,
EuropaBio organised
its first Workshop
on personalised
medicine
entitled:
General Scientific
Aspects
of
Personalised
Medicine: The
Healthcare Biotech
Industry
Perspective.
Attended by a large
audience of
policy-makers,
regulators and
industry experts,
the workshop
provided
participants with an
overview of the
scientific aspects
of personalised
medicines including,
among others, the
role of genomics in
the latest
developments of
personalised medical
applications or the
use of diagnostics
in clinical
development.
The presentations
can be downloaded as
follows:
For further
information about
this first workshop
or follow-on events,
please contact
Ludovic Lacaine,
Director, Healthcare
Biotech, EuropaBio
at:
l[dot]lacaine[at]europabio[dot]org
